Is Breast Cancer hereditary?

While most cases of breast cancer are sporadic and not inherited, approximately 5% to 10% of all breast cancer diagnoses are linked to an inherited genetic mutation. These hereditary cases typically follow an autosomal dominant inheritance pattern, meaning a mutation in a single gene copy from either parent can significantly increase lifetime risk.

Is breast cancer considered a hereditary condition?

It is important to distinguish between "genetic" and "hereditary." All breast cancer is technically genetic because it is caused by mutations in the DNA of breast cells. However, only a small minority of cases are hereditary, meaning the mutation was passed down from a parent through the germline. Most breast cancer occurs due to somatic mutations—random errors that happen in breast tissue cells over a person's lifetime due to aging and environmental exposures. Even in families with a strong history of the disease, many cases are considered "familial," likely due to a combination of shared lifestyle factors and multiple low-risk genetic variants rather than a single high-risk gene.

How are hereditary breast cancer risks passed down?

When breast cancer is hereditary, it often involves high-penetrance genes such as BRCA1 or BRCA2. These conditions follow an autosomal dominant inheritance pattern. If a parent carries a pathogenic mutation in one of these genes, each child has a 50% chance of inheriting that same mutation. It is important to note that inheriting a mutation does not mean a person will definitely develop the disease; rather, it means they have a significantly higher lifetime risk compared to the general population. While de novo (spontaneous) mutations in these genes can occur, they are relatively rare compared to inherited mutations in high-risk families.

When is genetic testing recommended for breast cancer?

Genetic testing is not recommended for everyone, but it is a critical tool for those with a significant family history. Clinical geneticists generally recommend testing for individuals who meet specific criteria, including:

• Personal history of breast cancer diagnosed at age 45 or younger.


• Personal history of triple-negative breast cancer diagnosed at age 60 or younger.


• Multiple primary breast cancers in the same individual.


• A family history of breast, ovarian, pancreatic, or prostate cancer, especially in multiple generations.


• Ashkenazi Jewish ancestry, which has a higher prevalence of specific BRCA1/2 founder mutations.

What is the role of genetic counseling in breast cancer management?

Genetic counseling is the cornerstone of navigating a hereditary breast cancer diagnosis. A counselor helps families interpret the results of genetic tests, assess the personal risk of developing cancer, and discuss risk-reduction strategies, such as increased surveillance (e.g., earlier or more frequent MRIs) or prophylactic surgeries. For those planning pregnancies, genetic counselors can discuss reproductive options, including Preimplantation Genetic Testing (PGT) for those who know they carry a high-risk mutation, allowing them to screen embryos to prevent passing the mutation to future generations.

Next steps

• Consult with a board-certified genetic counselor to review your family health history and determine if genetic testing is appropriate for you.


• Gather detailed health records from relatives, specifically noting the age of diagnosis and the type of cancer, as this is vital for accurate risk assessment.


• Join the DiseaseMaps.org community, where over 110 members share their personal experiences with breast cancer to find support and shared knowledge.


• Speak with an oncologist about personalized screening schedules if you have a known family history of breast cancer.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Cancer Institute (NCI): Genetics of Breast and Gynecologic Cancers.


• NIH Genetic and Rare Diseases Information Center (GARD): Breast Cancer.


• American College of Medical Genetics and Genomics (ACMG): Guidelines for Genetic Testing in Hereditary Breast Cancer.


• OMIM (Online Mendelian Inheritance in Man): Entry for Breast Cancer, Familial.